Alnylam Assist™: Getting Started

Hi, I’m Kevin

Your Local Case Manager

I’m here to personally help you get started with Alnylam Assist™. See below for how to begin.

Call me now to get started


Monday - Friday, 8am - 6pm

What You Will Need to Get Started

When you and your doctor choose to begin treatment with OXLUMO® (lumasiran) and to enroll in Alnylam Assist™, the next step is to complete the Start Form together.

Before you begin this process with your doctor, please take a few minutes to review the types of information you will need to fill out for your sections of the Start Form, especially if you have additional information you need to provide for a loved one:

Personal Information

Personal Information

This includes basic information like your name, date of birth, current mailing address, email, and phone number.

Alnylam Assist® - Understanding Your Benefits

Primary Insurance Information

This includes information found on your insurance card, if you have one. You will need your plan name, policy number, and group number, so be sure to have your insurance card available.

Alnylam Assist® Treatment Logistics Icon

Physician Information

In order to get started with Alnylam Assist™, your doctor is required to initiate your enrollment in the program and provide their information.

How to Begin the Start Form

The first step towards getting started with the Alnylam Assist™ is to complete the Start Form with your doctor.

Your doctor has options on how to do this. Doctors will either 1) complete the form with you present, or 2) begin the form by filling out their physician information, then share with you via email to complete your portion.

Then, your doctor will submit the form to Alnylam Assist™. Upon receipt of the Start Form, an Alnylam Case Manager will reach out to you and your doctor within 2 business days.

Alnylam Assist® - Website Icon

Want to learn more about OXLUMO?

Visit the OXLUMO patient website

Visit Website

What is the Alnylam Assist™ program?

The Alnylam Assist™ program offers you support throughout your treatment with an Alnylam product. This includes helping you understand your insurance coverage for your treatment and the options for financial support for which you may be eligible. Alnylam Assist will also provide materials that may help start conversations with your doctor and family about your treatment. See all of the support available ›

Alnylam Assist® - Questions Icon

Find answers to other

Frequently Asked Questions ›

Alnylam Assist® Case Manager Kevin

Call Kevin


Monday - Friday, 8am - 6pm

Alylam Separator Triangles


The most common side effect of OXLUMO is injection site reaction (redness, swelling, pain, bruising, itching, and discoloration at the site of injection). These are not all the possible side effects of OXLUMO. Talk to your doctor about side effects that you experience. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit, or call 1-800-FDA-1088.

OXLUMO has not been studied in pregnant or breastfeeding women. Talk to your doctor about the risk of taking OXLUMO if you are pregnant, plan to become pregnant, are breastfeeding, or plan to breastfeed.


OXLUMO is a prescription medicine for the treatment of primary hyperoxaluria type 1 (PH1) to lower oxalate in urine and blood in children and adults.

For additional information about OXLUMO, please see the full Prescribing Information.